SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
TranYan
Lv6
2420 积分
2022-12-16 加入
最近求助
最近应助
互助留言
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials
21小时前
已完结
Efficacy and safety of stapokibart (CM310) in adults with moderate-to-severe atopic dermatitis: a multicenter, randomized, double-blind, placebo-controlled phase 3 trial
2天前
已完结
[Comorbidity and multimorbidity for allergic diseases]
6天前
已完结
Increasing Prevalence of Allergic Disease and Its Impact on Current Practice
6天前
已完结
[Expert consensus on diagnosis, treatment and prevention of allergic diseases (Part Ⅰ)]
7天前
已完结
SKY59, A Novel Recycling Antibody for Complement-mediated Diseases
16天前
已完结
Crystal Structure of Bimekizumab Fab Fragment in Complex with IL-17F Provides Molecular Basis for Dual IL-17A and IL-17F Inhibition
30天前
已完结
IL-17A and IL-17F in tissue homeostasis, inflammation and regeneration
30天前
已完结
The establishment of humanized IL-4/IL-4RA mouse model by gene editing and efficacy evaluation
1个月前
已关闭
A Novel Inhalable Nanobody Targeting IL-4Rα for the Treatment of Asthma
1个月前
已完结
没有进行任何应助
感谢
21小时前
感谢
6天前
感谢
6天前
感谢
7天前
感谢
16天前
感谢
30天前
感谢
30天前
核实补充材料【积分已退回】
1个月前
感谢
1个月前
感谢
1个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论